{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-006326","form_type":"8-K","ticker":"ZURA","cik":"0001855644","company_name":"Zura Bio Ltd","filed_at":"2026-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.566645+00:00","generated_at":"2026-05-16T08:04:18.986631+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.9,"confidence":"high","headline":"Zura Bio announces CEO resignation and appointment of Sandeep Kulkarni as new CEO","bullets":["Robert Lisicki resigned as CEO and director effective January 21, 2026, after medical leave since October 2025.","Dr. Sandeep Kulkarni appointed CEO and continues as director; will receive $655,000 base salary and equity awards.","Separation agreement with Lisicki includes $72,000 annualized transition compensation through March 31, 2026.","Parvinder Thiara appointed to board effective January 23, 2026; previously served from 2022 to 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-006326","json":"https://secwatch.observer/filing/0001104659-26-006326.json","markdown":"https://secwatch.observer/filing/0001104659-26-006326.md","text":"https://secwatch.observer/filing/0001104659-26-006326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855644/000110465926006326/0001104659-26-006326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855644/000110465926006326/tm263758d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T08:04:18.986631+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}